US 11287427
Application of anti-CD39L3 antibodies for use in disease diagnostics and imaging
granted A61KA61K35/39A61P
Quick answer
US patent 11287427 (Application of anti-CD39L3 antibodies for use in disease diagnostics and imaging) held by THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
- Grant date
- Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K35/39, A61P, A61P3/08